Applying a clinical lens to animal models of CAR-T cell therapies: Molecular Therapy - Methods & Clinical Development
Modeling anti-CD19 CAR T cell therapy in humanized mice with human immunity and autologous leukemia - ScienceDirect
Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus | Cellular & Molecular Immunology
Modeling anti-CD19 CAR T cell therapy in humanized mice with human immunity and autologous leukemia - eBioMedicine
tMUC1-CAR T cells control pancreatic tumor growth in vivo. (A).... | Download Scientific Diagram
CAR T Cell Therapy, Are We There Yet?
Logic-gated CAR-T cells safely target distant tumor cells
Combined Antitumor Effects of Sorafenib and GPC3-CAR T Cells in Mouse Models of Hepatocellular Carcinoma: Molecular Therapy
Cancers | Free Full-Text | Humanized Mice Are Precious Tools for Preclinical Evaluation of CAR T and CAR NK Cell Therapies
Modeling anti-CD19 CAR T cell therapy in humanized mice with human immunity and autologous leukemia - ScienceDirect
Playing the blame game with cytokine release syndrome
A mouse model of CRS recapitulates clinical CAR T cell-induced CRS.... | Download Scientific Diagram
In vivo efficacy and safety of mouse anti-FITC CAR-T cells with... | Download Scientific Diagram
Optimized gene engineering of murine CAR-T cells reveals the beneficial effects of IL-15 coexpression | Journal of Experimental Medicine | Rockefeller University Press
Steering CAR T Cells into Solid Tumors | NEJM
Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus | Cellular & Molecular Immunology
Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18 - ScienceDirect
JCI Insight - A rational mouse model to detect on-target, off-tumor CAR T cell toxicity
Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA | Cell Discovery
Direct Delivery of piggyBac CD19 CAR T Cells Has Potent Anti-tumor Activity against ALL Cells in CNS in a Xenograft Mouse Model: Molecular Therapy - Oncolytics
Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice | PNAS
Preclinical Models in Chimeric Antigen Receptor–Engineered T-Cell Therapy | Human Gene Therapy
Custom CAR-T Development | AMSBIO
CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers | Nature Biomedical Engineering
JCI Insight - 4-1BB enhancement of CAR T function requires NF-κB and TRAFs
ACE CD19.CAR-T Cells Potently Reject CD19 + Leukemic Cells in a Mouse... | Download Scientific Diagram
